Drug details

Barhemsys (amisulpride injection, for intravenous use)

type of Antiemetic Agents

Barhemsys (amisulpride) is a dopamine-2 (D2) antagonist indicated in adults to prevent postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class, and to treat PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.

This drug may have the following side effects:

• chills,
• increased blood prolactin concentrations,
• low blood potassium (hypokalemia),
• procedural low blood pressure (hypotension),
• abdominal distension, and
• infusion site pain

The following drugs are related to Barhemsys, either as a replacement or used together:

• Alymsys (bevacizumab-maly injection)
• Anzemet Injection (dolasetron mesylate injection)
• Anzemet Tablets (dolasetron)
• Phenergan-Codeine (codeine phosphate and promethazine hcl)
• Compro (prochlorperazine suppositories)
• Ozurdex (dexamethasone intravitreal implant)
• Inapsine (droperidol)
• Kytril (granisetron)
• Sustol (granisetron extended-release injection)
• Sancuso (granisetron transdermal system)
• Ondansetron Hydrochloride (Zofran) (ondansetron hydrochloride tablets)
• Zofran Injection (ondansetron hydrochloride injection)
• Zofran (ondansetron hydrochloride tablets and solution)
• Phenergan (promethazine)
• Phenergan Vc (promethazine hcl and phenylephrine hcl syrup)
• Prochlorperazine Maleate Tablets (prochlorperazine maleate tablets)
• Promethazine HCl and Dextromethorphan Hydrobromide Syrup (promethazine and dextromethorphan)
• Promethazine HCl (promethazine hydrochloride)
• Promethazine HCl Injection (promethazine hydrochloride injection)
• Promethazine HCl Suppositories (promethazine hydrochloride suppositories)
• Promethazine HCl Syrup (promethazine hydrochloride syrup plain)
• Transderm Scop (scopolamine)